| Outcome . | Time Point . | Total Number of Patients . | No. Patients Who Stopped RZB or Dropped Out of Follow-up Before the Time Point . | No. Patients Who Continued RZB but Required Intestinal Resection Before the Time Point . | No. Patients Who Achieved the Outcome Without Requiring Intestinal Resection . | Percentage of Patients Who Achieved the Outcome on ITT Basis . |
|---|---|---|---|---|---|---|
| Steroid-free Clinical Remission | Week 24 | 55 | 1 | 1 | 10 | 18.2% |
| Clinical Remission | Week 24 | 55 | 1 | 1 | 10 | 18.2% |
| Steroid-free Clinical Response | Week 24 | 55 | 1 | 1 | 34 | 61.8% |
| Clinical Response | Week 24 | 55 | 1 | 1 | 36 | 65.5% |
| Steroid-free Clinical Remission | Week 52 | 55 | 7 | 3 | 15 | 27.3% |
| Clinical Remission | Week 52 | 55 | 7 | 3 | 15 | 27.3% |
| Steroid-free Clinical Response | Week 52 | 55 | 7 | 3 | 32 | 58.2% |
| Clinical Response | Week 52 | 55 | 7 | 3 | 33 | 60.0% |
| Outcome . | Time Point . | Total Number of Patients . | No. Patients Who Stopped RZB or Dropped Out of Follow-up Before the Time Point . | No. Patients Who Continued RZB but Required Intestinal Resection Before the Time Point . | No. Patients Who Achieved the Outcome Without Requiring Intestinal Resection . | Percentage of Patients Who Achieved the Outcome on ITT Basis . |
|---|---|---|---|---|---|---|
| Steroid-free Clinical Remission | Week 24 | 55 | 1 | 1 | 10 | 18.2% |
| Clinical Remission | Week 24 | 55 | 1 | 1 | 10 | 18.2% |
| Steroid-free Clinical Response | Week 24 | 55 | 1 | 1 | 34 | 61.8% |
| Clinical Response | Week 24 | 55 | 1 | 1 | 36 | 65.5% |
| Steroid-free Clinical Remission | Week 52 | 55 | 7 | 3 | 15 | 27.3% |
| Clinical Remission | Week 52 | 55 | 7 | 3 | 15 | 27.3% |
| Steroid-free Clinical Response | Week 52 | 55 | 7 | 3 | 32 | 58.2% |
| Clinical Response | Week 52 | 55 | 7 | 3 | 33 | 60.0% |
Abbreviations: RZB, risankizumab; ITT, intention-to-treat
| Outcome . | Time Point . | Total Number of Patients . | No. Patients Who Stopped RZB or Dropped Out of Follow-up Before the Time Point . | No. Patients Who Continued RZB but Required Intestinal Resection Before the Time Point . | No. Patients Who Achieved the Outcome Without Requiring Intestinal Resection . | Percentage of Patients Who Achieved the Outcome on ITT Basis . |
|---|---|---|---|---|---|---|
| Steroid-free Clinical Remission | Week 24 | 55 | 1 | 1 | 10 | 18.2% |
| Clinical Remission | Week 24 | 55 | 1 | 1 | 10 | 18.2% |
| Steroid-free Clinical Response | Week 24 | 55 | 1 | 1 | 34 | 61.8% |
| Clinical Response | Week 24 | 55 | 1 | 1 | 36 | 65.5% |
| Steroid-free Clinical Remission | Week 52 | 55 | 7 | 3 | 15 | 27.3% |
| Clinical Remission | Week 52 | 55 | 7 | 3 | 15 | 27.3% |
| Steroid-free Clinical Response | Week 52 | 55 | 7 | 3 | 32 | 58.2% |
| Clinical Response | Week 52 | 55 | 7 | 3 | 33 | 60.0% |
| Outcome . | Time Point . | Total Number of Patients . | No. Patients Who Stopped RZB or Dropped Out of Follow-up Before the Time Point . | No. Patients Who Continued RZB but Required Intestinal Resection Before the Time Point . | No. Patients Who Achieved the Outcome Without Requiring Intestinal Resection . | Percentage of Patients Who Achieved the Outcome on ITT Basis . |
|---|---|---|---|---|---|---|
| Steroid-free Clinical Remission | Week 24 | 55 | 1 | 1 | 10 | 18.2% |
| Clinical Remission | Week 24 | 55 | 1 | 1 | 10 | 18.2% |
| Steroid-free Clinical Response | Week 24 | 55 | 1 | 1 | 34 | 61.8% |
| Clinical Response | Week 24 | 55 | 1 | 1 | 36 | 65.5% |
| Steroid-free Clinical Remission | Week 52 | 55 | 7 | 3 | 15 | 27.3% |
| Clinical Remission | Week 52 | 55 | 7 | 3 | 15 | 27.3% |
| Steroid-free Clinical Response | Week 52 | 55 | 7 | 3 | 32 | 58.2% |
| Clinical Response | Week 52 | 55 | 7 | 3 | 33 | 60.0% |
Abbreviations: RZB, risankizumab; ITT, intention-to-treat
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
